The Purpose of the Study is to Investigate if a Smartphone App Combined With Internet Based Cognitive Behavioural Therapy (ICBT) Leads to Improved Symtoms in Depressive Adults on Antidepressive Medicine, Compared to a Wait-list Control Condition
FIG
A Controlled Trial of Smartphone-delivered Cognitive Behavioral Therapy for Adults Treated With Medication for Depressive Symptoms
1 other identifier
interventional
150
1 country
1
Brief Summary
The purpose of the study is to investigate if a smartphone app combined with internet delivered cognitive behavioural therapy (ICBT) leads to improved symptoms in depressive adults on antidepressive mediation. The participants in the treatment group will get access to a smartphone app based on CBT-principles for 9 weeks. They will also get access to an internet platform with extra treatment material based on CBT and receive therapist support on demand. Participants will be recruited in Sweden with nationwide recruitment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 2, 2024
CompletedFirst Submitted
Initial submission to the registry
December 20, 2024
CompletedFirst Posted
Study publicly available on registry
April 2, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2028
December 2, 2025
November 1, 2025
1.6 years
December 20, 2024
November 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Montgomery Asberg Depression Ranging Scale (MADRS)
MADRS-S is a questionnaire including nine questions about depressive mental states. The questions aslo address experienced worry, ability to concentrate and initiative. Each question gives between 0 and 6 points. Maximum score is 54 points. Higher scores indicate higher levels of depression.
From enrollment to end of treament at 9 weeks. Follow-ups at 24 and 36 months after end of treatment.
Secondary Outcomes (2)
Generalized Anxiety Disorder-7
From enrollment to end of treament at 9 weeks. Follow-ups at 24 and 36 months after end of treatment.
Brunnsviken Brief Quality of life scale
From enrollment to end of treament at 9 weeks. Follow-ups at 24 and 36 months after end of treatment.
Other Outcomes (3)
Patient Health Questionnaire - 4
From enrollment on a weekly basis through study completion 9 weeks later.
Client Satisfaction Questionnaire
At week 9 following enrollment.
The Morisky Medication Adherence Scale
From enrollment to end of treament at 9 weeks.
Study Arms (2)
Smartphone delivered Internet-based Cognitive Behavioural Therapy
EXPERIMENTALThe treatment consist of a 9 week long ICBT intervention based on an smartphone app with therapist support on demand.
No Intervention: Wait-list control condition
NO INTERVENTIONWait-list control condition, participants have the option to contact the treatment team in case of worsened symptoms.
Interventions
The intervention is 9 week long were partipants use an smartphone app based on CBT-principles with while having access to an internet platform where extra working material and therapist support is available on demand.
Eligibility Criteria
You may qualify if:
- Ongoing drug treatment with an antidepressant mediated by an established care contact in (primary) care.
- years or older.
- Be able to speak, read and write Swedish.
- Have access to a computer, tablet or other device with internet connection and smartphone to download the app.
You may not qualify if:
- Severe psychiatric or somatic problems that make participation difficult or impossible
- Ongoing abuse (via Audit and during interview)
- Acute suicidality
- Other ongoing psychological treatment or planned investigation.
- Planned dose change of medicine or change of medicine during pre-measurement.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Linköping University
Linköping, Östergötland County, 58183, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD, Professor
Study Record Dates
First Submitted
December 20, 2024
First Posted
April 2, 2025
Study Start
November 2, 2024
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
September 1, 2028
Last Updated
December 2, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will share
De-identified individual participant data will be shared on request following initial publication of results.